Dr. Agarwal's Health Care credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025
157157247
−124−124−275
0.07×0.07×0.13×
−0.06×−0.06×−0.14×
0.28×0.28×0.54×
−0.20×−0.22×−0.60×
3.24×3.24×2.07×
6.9%6.9%11.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AGARWALEYE₹488.70

Dr. Agarwal's Health Care Ltd.

· Pharma & Health
₹ CrorePeersAKUMSADVENZYMESALIVUSAARTIPHARMAARTIDRUGSAPLLTDCORONAHCGMcap ₹15,482 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt246.9157.3157.3
Net Debt-275.0-124.3-124.3
Total Debt/Equity0.130.070.07
Net Debt/Equity-0.14-0.06-0.06
Total Debt/EBITDA0.540.280.28
Net Debt/EBITDA-0.60-0.22-0.20
Interest Coverage (EBIT/Interest)2.073.243.24
Total Debt/Total Capital %11.366.916.91
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.